Effect of single-dose methotrexate on ovarian reserve in women with ectopic pregnancy

Objective To evaluate ovarian reserve in women with ectopic pregnancy treated with single-dose systemic methotrexate in the early post-treatment period. Design Prospective study. Setting Women’s health education and research hospital. Patient (s) Eighty-two patients with ectopic pregnancy and 80 hea...

Full description

Saved in:
Bibliographic Details
Published inFertility and sterility Vol. 100; no. 5; pp. 1310 - 1313
Main Authors Uyar, Ibrahim, M.D, Yucel, Onur Umut, M.D, Gezer, Cenk, M.D, Gulhan, Ibrahim, M.D, Karis, Buket, M.D, Hanhan, H. Merih, M.D, Ozeren, Mehmet, M.D
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.11.2013
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Objective To evaluate ovarian reserve in women with ectopic pregnancy treated with single-dose systemic methotrexate in the early post-treatment period. Design Prospective study. Setting Women’s health education and research hospital. Patient (s) Eighty-two patients with ectopic pregnancy and 80 healthy women in the same age group were included in the study. Of the 82 patients, 49 with ectopic pregnancy were treated with single-dose systemic methotrexate (MTX) and 33 were treated surgically with laparoscopy or laparotomy (salpingectomy or salpingostomy). Intervention(s) Ovarian reserve testing. Main Outcome Measure(s) Basal FSH on the 3rd day of the menstrual cycle, E2 , basal antral follicle count (AFC), and ovarian volume. Result(s) There were no differences among the groups in terms of basal FSH, E2 , AFC, and ovarian volume. Conclusion(s) The single-dose MTX treatment had no effect on ovarian reserve in women with ectopic pregnancy as measured by the above-mentioned parameters.
Bibliography:http://dx.doi.org/10.1016/j.fertnstert.2013.06.040
ISSN:0015-0282
1556-5653
DOI:10.1016/j.fertnstert.2013.06.040